These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 33200031)

  • 1. Comparison of efficacy of dexamethasone and methylprednisolone in moderate to severe covid 19 disease.
    Fatima SA; Asif M; Khan KA; Siddique N; Khan AZ
    Ann Med Surg (Lond); 2020 Dec; 60():413-416. PubMed ID: 33200031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients.
    Saeed MAM; Mohamed AH; Owaynat AH
    Egypt J Intern Med; 2022; 34(1):19. PubMed ID: 35194371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of the Efficacy of Adjuvant Parenteral Methylprednisolone and Dexamethasone in Reducing Covid-19 Disease Severity and Mortality among the Moderate to Critical Patients -A Retrospective Study.
    Krishnaswamy P; Bs N; Hegde SV
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Tocilizumab-an option for patients with COVID-19 associated cytokine release syndrome: A single center experience", a retrospective study-original article.
    Chachar AZK; Khan KA; Iqbal J; Shahid AH; Asif M; Fatima SA; Khan AA; Younis BB
    Ann Med Surg (Lond); 2021 Mar; 63():102165. PubMed ID: 33585031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone or methylprednisolone therapy in covid-19 pneumonia: A retrospective and comparative study of 513 cases.
    El Mezzeoui S; El Aidouni G; Merbouh M; El Kaouini A; Aftiss FZ; Berrichi S; Berrajaa S; Bkiyer H; Abda N; Housni B
    Ann Med Surg (Lond); 2021 Oct; 70():102858. PubMed ID: 34545308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Efficacy of Dexamethasone and Methylprednisolone in Improving PaO2/FiO2 Ratio Among COVID-19 Patients.
    Rana MA; Hashmi M; Qayyum A; Pervaiz R; Saleem M; Munir MF; Ullah Saif MM
    Cureus; 2020 Oct; 12(10):e10918. PubMed ID: 33194485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.
    Busani S; Tosi M; Mighali P; Vandelli P; D'Amico R; Marietta M; Forfori F; Donati A; Cinnella G; De Monte A; Pasero D; Bellani G; Tascini C; Foti G; Ranieri M; Girardis M
    Trials; 2020 Aug; 21(1):724. PubMed ID: 32807241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of Methylprednisolone and Dexamethasone in Intensive Care Patients With COVID-19.
    Ko JJ; Wu C; Mehta N; Wald-Dickler N; Yang W; Qiao R
    J Intensive Care Med; 2021 Jun; 36(6):673-680. PubMed ID: 33632000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia.
    Aomar-Millán IF; Fatoul-Del Pino G; Torres-Parejo Ú; Pérez-Fernández L; Martínez-Diz S; Salvatierra J
    Med Clin (Barc); 2023 Feb; 160(4):156-159. PubMed ID: 35987733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of methylprednisolone pulse vs conventional dexamethasone for adult cases of COVID-19 requiring oxygen; a Japanese retrospective cohort study.
    Watanabe Y; Nakamura I; Sato S; Fujita H; Kobayashi T; Watanabe H
    J Infect Chemother; 2023 Mar; 29(3):269-273. PubMed ID: 36436740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Demographic Characteristics Including Comorbidities and Their Outcomes Among Patients Hospitalized With COVID-19 in Four Tertiary Care Hospitals Across Lahore.
    Khan Chachar AZ; Khan K; Khan AA; Muhammad Imran Hasan K; Ashraf Zia M; Siddique N; Bin Younis B; Khan ZA
    Cureus; 2021 Jan; 13(1):e12663. PubMed ID: 33604203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Low-Versus High-Dose Steroids in the Clinical Outcome of Hospitalized COVID-19 Patients.
    Jamil Z; Almajhdi FN; Khalid S; Asghar M; Ahmed J; Waheed Y
    Antibiotics (Basel); 2021 Dec; 10(12):. PubMed ID: 34943722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia.
    Aomar-Millán IF; Fatoul-Del Pino G; Torres-Parejo Ú; Pérez Fernández L; Martínez-Diz S; Salvatierra J
    Med Clin (Engl Ed); 2023 Feb; 160(4):156-159. PubMed ID: 36713976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: a randomized clinical trial.
    Dastenae ZH; Bahadori A; Dehghani M; Asadi-Samani M; Izadi I; Shahraki HR
    Int J Infect Dis; 2022 Sep; 122():659-664. PubMed ID: 35817286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19.
    Abbasian L; Toroghi N; Rahmani H; Khalili H; Hasannezhad M; Ghiasvand F; Jafari S; Salehi M; Salahshour F; Azadbakhsh Kanaf Gorabi M; Alizade F; Ghaderkhani S; Nakhostin M
    Int Immunopharmacol; 2022 Jun; 107():108689. PubMed ID: 35313272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Methylprednisolone on Ventilator-Free Days in Mechanically Ventilated Patients with Acute Respiratory Distress Syndrome and COVID-19: A Retrospective Study.
    Badr M; De Oliveira B; Abdallah K; Nadeem A; Varghese Y; Munde D; Salam S; Abduljawad B; Saleh K; Elkambergy H; Taha A; Bayrlee A; Wahla A; Dibu J; Haque R; Hamed F; Rahman N; Mallat J
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33672805
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison between Dexamethasone and Methylprednisolone Therapy in Patients with COVID-19 Pneumonia Admitted to Non-Intensive Medical Units.
    Buso R; Cinetto F; Dell'Edera A; Veneran N; Facchini C; Biscaro V; Schiavon S; Vian E; Grossi U; Zanus G; Giobbia M; Scarpa R; Agostini C; Rattazzi M; Felice C
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Clinical Outcome between Dexamethasone and Methyl Prednisolone in Treatment of Moderate to Severe COVID-19: A Systematic Review and Meta-Analysis.
    Mohanty RR; Das S; Padhy BM; Meher BR
    J Assoc Physicians India; 2022 Jan; 70(1):11-12. PubMed ID: 35062806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and therapeutic outcomes of COVID-19 intensive care units (ICU) patients: a retrospective study in Ghana.
    Afriyie-Mensah J; Aboagye ET; Ganu VJ; Bondzi S; Tetteh D; Kwarteng E; Akamah J; Doku A; Adjei P
    Pan Afr Med J; 2021; 38():107. PubMed ID: 33912277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.